JHOP Articles

Skip to main content

Original Research, Lymphoma, Immunotherapy, Infections, Monoclonal Antibodies

Hepatitis B Virus Infection Monitoring in Patients with Lymphoma Receiving Anti-CD20 Monoclonal Antibodies

Christopher Sinoimeri, PharmD, Bryan Do, PharmD, BCOP, Sheree Chen, PharmD, BCOP

Christopher Sinoimeri, PharmD; Bryan Do, PharmD, BCOP; Sheree Chen, PharmD, BCOP

ASCO Highlights, Bladder Cancer

Sacituzumab plus Pembrolizumab Shows Promising Antitumor Activity in Metastatic Urothelial Cancer

FDA Updates, Prostate Cancer

Pluvicto FDA Approved for PSMA-Positive Metastatic Prostate Cancer

ASCO Highlights, Prostate Cancer

Darolutamide plus ADT and Docetaxel Improves Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer

ASCO Highlights, Prostate Cancer

Continuous Treatment with Enzalutamide and Docetaxel Reduces the Risk for Progression in Patients with Metastatic Castration-Resistant Prostate Cancer

FDA Updates, Lung Cancer, Checkpoint Inhibitors

Opdivo plus Platinum-Based Chemotherapy FDA Approved as First Neoadjuvant Treatment in Early-Stage NSCLC

FDA Updates, Breast Cancer

Lynparza Receives FDA Approval for Adjuvant Treatment of High-Risk Early Breast Cancer with BRCA Mutation

FDA Updates, Gynecologic Cancers, Checkpoint Inhibitors, Screening

Keytruda Monotherapy FDA Approved for Endometrial Carcinoma with a Biomarker

FDA Updates, CAR T-Cell Therapy, Multiple Myeloma

Carvykti Second BCMA-Directed CAR T-Cell Therapy FDA Approved for Multiple Myeloma

FDA Updates, Melanoma, Immunotherapy

Opdualag, a Novel Immunotherapy Combination, FDA Approved for Advanced Melanoma

Page 52 of 196
Results 511 - 520 of 1953